Animal models of sepsis and its complications
- 1 October 2008
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 74 (8) , 991-993
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Understanding the Inflammatory Cytokine Response in Pneumonia and SepsisArchives of internal medicine (1960), 2007
- Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysisBMC Anesthesiology, 2007
- Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational studyIntensive Care Medicine, 2007
- Activated protein C: do more survive?Intensive Care Medicine, 2005
- Acute Renal Failure in Critically Ill PatientsA Multinational, Multicenter StudyJAMA, 2005
- Challenge and Rechallenge: Drotrecogin alfa (activated)–Induced Prolongation of Activated Partial Thromboplastin Time in a Patient with Severe SepsisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001